Effect of empagliflozin on worsening heart failure events in patients with heart failure and preserved ejection fraction: EMPEROR-preserved trial
Background: Empagliflozin reduces the risk of cardiovascular death or hospitalization for
heart failure in patients with heart failure with preserved ejection fraction, but additional data …
heart failure in patients with heart failure with preserved ejection fraction, but additional data …
Effect of Empagliflozin on Worsening Heart Failure Events in Patients With Heart Failure and Preserved Ejection Fraction: EMPEROR-Preserved Trial
M Packer, J Butler, F Zannad, G Filippatos… - …, 2021 - ingentaconnect.com
Background: Empagliflozin reduces the risk of cardiovascular death or hospitalization for
heart failure in patients with heart failure with preserved ejection fraction, but additional data …
heart failure in patients with heart failure with preserved ejection fraction, but additional data …
Effect of Empagliflozin on Worsening Heart Failure Events in Patients With Heart Failure and Preserved Ejection Fraction: EMPEROR-Preserved Trial.
M Packer, J Butler, F Zannad, G Filippatos… - …, 2021 - researchonline.lshtm.ac.uk
BACKGROUND: Empagliflozin reduces the risk of cardiovascular death or hospitalization for
heart failure in patients with heart failure with preserved ejection fraction, but additional data …
heart failure in patients with heart failure with preserved ejection fraction, but additional data …
Effect of Empagliflozin on Worsening Heart Failure Events in Patients With Heart Failure and Preserved Ejection Fraction: EMPEROR-Preserved Trial.
M Packer, J Butler, F Zannad, G Filippatos, JP Ferreira… - Circulation, 2021 - europepmc.org
Background Empagliflozin reduces the risk of cardiovascular death or hospitalization for
heart failure in patients with heart failure with preserved ejection fraction, but additional data …
heart failure in patients with heart failure with preserved ejection fraction, but additional data …
Effect of Empagliflozin on Worsening Heart Failure Events in Patients With Heart Failure and Preserved Ejection Fraction: EMPEROR-Preserved Trial
M Packer, J Butler, F Zannad, G Filippatos… - …, 2021 - research.regionh.dk
BACKGROUND: Empagliflozin reduces the risk of cardiovascular death or hospitalization for
heart failure in patients with heart failure with preserved ejection fraction, but additional data …
heart failure in patients with heart failure with preserved ejection fraction, but additional data …
Effect of Empagliflozin on Worsening Heart Failure Events in Patients with Heart Failure and a Preserved Ejection Fraction: The EMPEROR-Preserved Trial
M Packer, J Butler, F Zannad, G Filippatos, JP Ferreira… - Circulation, 2021 - hal.science
Background: Empagliflozin reduces the risk of cardiovascular death or hospitalization for
heart failure in patients with heart failure and a preserved ejection fraction, but additional …
heart failure in patients with heart failure and a preserved ejection fraction, but additional …
Effect of Empagliflozin on Worsening Heart Failure Events in Patients with Heart Failure and a Preserved Ejection Fraction: The EMPEROR-Preserved Trial
M Packer, J Butler, F Zannad, G Filippatos, JP Ferreira… - Circulation, 2021 - inria.hal.science
Background: Empagliflozin reduces the risk of cardiovascular death or hospitalization for
heart failure in patients with heart failure and a preserved ejection fraction, but additional …
heart failure in patients with heart failure and a preserved ejection fraction, but additional …
Effect of Empagliflozin on Worsening Heart Failure Events in Patients With Heart Failure and Preserved Ejection Fraction: EMPEROR-Preserved Trial
M Packer, J Butler, F Zannad, G Filippatos, JP Ferreira… - Circulation, 2021 - cir.nii.ac.jp
抄録< jats: sec>< jats: title> Background:</jats: title>< jats: p> Empagliflozin reduces the risk
of cardiovascular death or hospitalization for heart failure in patients with heart failure with …
of cardiovascular death or hospitalization for heart failure in patients with heart failure with …
Effect of Empagliflozin on Worsening Heart Failure Events in Patients With Heart Failure and Preserved Ejection Fraction: EMPEROR-Preserved Trial
M Packer, J Butler, F Zannad, G Filippatos, JP Ferreira… - 2021 - pubmed.ncbi.nlm.nih.gov
Background Empagliflozin reduces the risk of cardiovascular death or hospitalization for
heart failure in patients with heart failure with preserved ejection fraction, but additional data …
heart failure in patients with heart failure with preserved ejection fraction, but additional data …
Effect of Empagliflozin on Worsening Heart Failure Events in Patients With Heart Failure and Preserved Ejection Fraction
EP Trial - Circulation, 2021 - Am Heart Assoc
BACKGROUND: Empagliflozin reduces the risk of cardiovascular death or hospitalization for
heart failure in patients with heart failure with preserved ejection fraction, but additional data …
heart failure in patients with heart failure with preserved ejection fraction, but additional data …